Nuwellis (NUWE) Invested Capital (2015 - 2016)
Nuwellis' (NUWE) quarterly Invested Capital came in at $9.6 million in Q2 2016, down 63.69% on a YoY basis from $26.4 million in Q3 2015, and down 33.45% quarter-over-quarter from $14.4 million in Q1 2016.
Powered by 
Analysis
Nuwellis (NUWE) Invested Capital (2015 - 2016) Analysis & Trends
Nuwellis (NUWE) has reported Invested Capital for 2 consecutive years, with $9.6 million the latest figure, recorded in Q2 2016.
- For the quarter ending Q2 2016, Invested Capital fell 63.69% year-over-year to $9.6 million; the trailing twelve-month figure through Jun 2016 stood at $9.6 million (down 63.69% YoY), and the FY2015 full-year result was $19.8 million, changed N/A from the prior year.
- Invested Capital retreated to $9.6 million in Q2 2016 per NUWE's latest filing, from $14.4 million in the prior quarter.
- Across five years, Invested Capital topped out at $30.8 million in Q1 2015 and bottomed at $9.6 million in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.37 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 79.00 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 38.93 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.80 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 11.32 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 25.74 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 9.36 Bn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 9.59 Mn |
| Mar 31, 2016 | 14.41 Mn |
| Dec 31, 2015 | 19.85 Mn |
| Sep 30, 2015 | 21.30 Mn |
| Jun 30, 2015 | 26.42 Mn |
| Mar 31, 2015 | 30.78 Mn |